Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors

Clinical trial NCT06195384 · RECRUITING

Trial details

NCT number: NCT06195384
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2024-05-08
Primary completion: 2027-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.